Basket Study Shows Early Efficacy Targeting Cancer Only On Alterations

Email not displaying correctly? View it in your browser.
  Lab and Pathology Insider Logo  
Feb 6, 2018  
placeholder  EMERGING TESTS
Basket Study Shows Early Efficacy Targeting Cancer Only On Alterations
From - Diagnostic Testing & Emerging Technologies
Early results from an ongoing "basket study" show that targeted therapies may be effective strictly based on the tumor's molecular profile, and not primary tumor type…
Read More

placeholder  MANAGING STAFF
Compliance Perspectives: Can You Require Lab Workers to Get a Flu Shot?
From - G2 Compliance Advisor
Bottom Line on Top: Yes, a mandatory flu vaccination policy is legally justifiable as long as…
Read More
     


placeholder  INSIDE THE LAB INDUSTRY
PAMA-geddon: Lab Industry Asks Court to Stop New Medicare Fee Schedule
From - Laboratory Industry Report
With CMS refusing to back down, the lab industry has escalated the dispute and asked a U.S. District Court to step in and prevent enforcement of the 2018 PAMA-inspired…
Read More

placeholder  ENFORCEMENT
EHR: Private Whistleblowers Getting in on "Meaningful Use" Crackdown
From - National Intelligence Report
Wrongful payment of electronic health records (EHR) "meaningful use" incentives has become a growth area in federal health care fraud enforcement…
Read More

 


For questions concerning delivery of this email, please contact customer service at:
(888) 729-2315 | customerservice@plainlanguagemedia.com

Copyright © 2018, All rights reserved.
Plain Language Media LLLP
PO Box 509, New London, CT 06320